The dominant role of CD8+dendritic cells in cross-presentation is not dictated by antigen capture
- 11 July 2006
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (28) , 10729-10734
Abstract
Mouse spleens contain three populations of conventional (CD11chigh) dendritic cells (DCs) that play distinct functions. The CD8+DC are unique in that they can present exogenous antigens on their MHC class I molecules, a process known as cross-presentation. It is unclear whether this special ability is because only the CD8+DC can capture the antigens used in cross-presentation assays, or because this is the only DC population that possesses specialized machinery for cross-presentation. To solve this important question we examined the splenic DC subsets for their ability to both present via MHC class II molecules and cross-present via MHC class I using four different forms of the model antigen ovalbumin (OVA). These forms include a cell-associated form, a soluble form, OVA expressed in bacteria, or OVA bound to latex beads. With the exception of bacterial antigen, which was poorly cross-presented by all DC, all antigenic forms were cross-presented much more efficiently by the CD8+DC. This pattern could not be attributed simply to a difference in antigen capture because all DC subsets presented the antigen via MHC class II. Indeed, direct assessments of endocytosis showed that CD8+and CD8−DC captured comparable amounts of soluble and bead-associated antigen, yet only the CD8+DC cross-presented these antigenic forms. Our results indicate that cross-presentation requires specialized machinery that is expressed by CD8+DC but largely absent from CD8−DC. This conclusion has important implications for the design of vaccination strategies based on antigen targeting to DC.Keywords
This publication has 45 references indexed in Scilit:
- Langerhans cells cross-present antigen derived from skinProceedings of the National Academy of Sciences, 2006
- Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes developmentInternational Immunology, 2005
- Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosisBlood, 2004
- Most lymphoid organ dendritic cell types are phenotypically and functionally immatureBlood, 2003
- Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell MaturationJournal of Experimental Medicine, 2003
- The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated AntigensJournal of Experimental Medicine, 2002
- Constitutive versus Activation-dependent Cross-Presentation of Immune Complexes by CD8+ and CD8− Dendritic Cells In VivoJournal of Experimental Medicine, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- T cell receptor antagonist peptides induce positive selectionCell, 1994
- Role of self-peptides in positively selecting the T-cell repertoireNature, 1990